Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07125053 · ClinicalTrials.gov registry record · NA
COPD Resources, Education, and Activity Designed for You Study
A NA study of COPD, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 448
- Enrollment target
- 1
- Study location
NCT07125053: Recruiting NA study of COPD, sponsored by Rush University Medical Center.
NCT07125053 is a NA study of COPD that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 448 participants, below the 2,413-participant average among 85 other COPD trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07125053, a NA study of COPD, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
- 1
- Study location
Study Summary
Although COPD self-management treatment programs are effective in reducing COPD-related hospitalizations and increasing quality of life, there is a limited understanding of 'how and why' they work. The proposed research will use an engineering-inspired study design to identify effective COPD self-management treatment components and guide its 'real world' implementation. The long-term goal of this line of research is to build an optimized COPD self-management program, and scale the program up to reduce the burden of COPD at a population health level.
Primary Outcome
Incidence of one or more respiratory-related hospitalization at 12-month follow-up
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity
- BEHAVIORAL Education (self-guided)
- BEHAVIORAL Education (counselor-led)
- BEHAVIORAL Inhaler Training
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2029-09-01 |
| Phase | NA |
What NCT07125053 shows while recruiting
NCT07125053 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, below the 2,413-participant average among 85 other COPD trials with a reported enrollment target (81% lower).
The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 4 interventions - of which Physical Activity is the first listed.
NCT07125053 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07125053 about?
NCT07125053 is a clinical study titled "COPD Resources, Education, and Activity Designed for You Study". Although COPD self-management treatment programs are effective in reducing COPD-related hospitalizations and increasing quality of life, there is a limited understanding of 'how and why' they work. The proposed research will use an engineering-inspired study design to identify effective COPD self-ma...
What is the current status of trial NCT07125053?
This trial is currently recruiting. It is a NA study. The enrollment target is 448 participants. The study started on 2025-08-18. Estimated completion is 2029-09-01.
What conditions does trial NCT07125053 study?
This clinical trial studies the following conditions: COPD.
What interventions are being tested in trial NCT07125053?
The interventions under investigation include: Physical Activity (BEHAVIORAL), Education (self-guided) (BEHAVIORAL), Education (counselor-led) (BEHAVIORAL), Inhaler Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07125053?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07125053 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07125053's enrollment target sits among peer trials
448 18th of 85 higher than 68 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI